Key Market Indicators
Sales of antacid medicines in Sweden are forecast to reach around $13.15 million by 2026, up from $12.54 million in 2021. Since 2005, the Swedish market has grown by an average of 2.3% each year. Belgium currently leads the way in 2021, with sales of $12.54 million, followed by Italy, Germany and Chile at numbers two, three and four, respectively.
